Janusz J Stańczak Selected Research

Chronic Hepatitis B

1/2006	[Results of 48 weeks lamivudine treatment of patients with chronic hepatitis B and HBeAg (+)].
1/2006	[Results of 48 weeks lamivudine treatment of patients with chronic hepatitis B and HBeAg (-)].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Janusz J Stańczak Research Topics

Disease

3	Fibrosis (Cirrhosis) 09/2014 - 01/2006
3	Chronic Hepatitis C 09/2014 - 01/2006
2	Renal Insufficiency (Renal Failure) 01/2006 - 01/2006
2	Liver Diseases (Liver Disease) 01/2006 - 01/2006
2	Chronic Hepatitis B 01/2006 - 01/2006
1	Liver Failure 01/2006
1	Infections 01/2006
1	Anemia 01/2006

Drug/Important Bio-Agent (IBA)

3	Ribavirin (Virazole)FDA LinkGeneric 09/2014 - 01/2006
2	peginterferon alfa-2b (Pegintron)FDA Link 09/2014 - 01/2006
2	Hepatitis B e AntigensIBA 01/2006 - 01/2006
2	Lamivudine (Epivir)FDA Link 01/2006 - 01/2006
1	peginterferon alfa-2a (Pegasys)FDA Link 09/2014
1	RNA (Ribonucleic Acid)IBA 09/2014
1	InterferonsIBA 01/2006
1	AntigensIBA 01/2006
1	interferon alfacon-1 FDA Link 01/2006

Therapy/Procedure

3	Therapeutics 01/2006 - 01/2006